92 related articles for article (PubMed ID: 7907269)
1. [CD2-mediated T-lymphocyte proliferation in patients with systemic lupus erythematosus].
Tang FL
Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):661-3, 701. PubMed ID: 7907269
[TBL] [Abstract][Full Text] [Related]
2. Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction.
Horwitz DA; Tang FL; Stimmler MM; Oki A; Gray JD
Arthritis Rheum; 1997 May; 40(5):822-33. PubMed ID: 9153542
[TBL] [Abstract][Full Text] [Related]
3. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
4. [The classical and alternative pathways of T-lymphocyte activation in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 1999; 71(5):30-4. PubMed ID: 10399227
[TBL] [Abstract][Full Text] [Related]
5. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
[TBL] [Abstract][Full Text] [Related]
6. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA
Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171
[TBL] [Abstract][Full Text] [Related]
7. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
[TBL] [Abstract][Full Text] [Related]
8. Defective CD2 pathway T cell activation in systemic lupus erythematosus.
Fox DA; Millard JA; Treisman J; Zeldes W; Bergman A; Depper J; Dunne R; McCune WJ
Arthritis Rheum; 1991 May; 34(5):561-71. PubMed ID: 1673843
[TBL] [Abstract][Full Text] [Related]
9. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
10. Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase.
Nel AE; Ledbetter JA; Williams K; Ho P; Akerley B; Franklin K; Katz R
Immunology; 1991 Jun; 73(2):129-33. PubMed ID: 1676984
[TBL] [Abstract][Full Text] [Related]
11. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
Tutt A; Stevenson GT; Glennie MJ
J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
[TBL] [Abstract][Full Text] [Related]
12. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
13. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
[TBL] [Abstract][Full Text] [Related]
14. Human CD2 is functional in CD2 transgenic mice.
Monostori E; Lang G; Kioussis D; Cantrell DA; Zamoyska R; Brown MH; Crumpton MJ
Immunology; 1991 Nov; 74(3):369-72. PubMed ID: 1685144
[TBL] [Abstract][Full Text] [Related]
15. CD44 contributes to T cell activation.
Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
[TBL] [Abstract][Full Text] [Related]
16. Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.
Suthanthiran M
Transplant Proc; 1987 Feb; 19(1 Pt 1):336-7. PubMed ID: 2908550
[No Abstract] [Full Text] [Related]
17. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
[TBL] [Abstract][Full Text] [Related]
18. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD3 and anti-CD2-induced T-cell activation in primary Sjögren's syndrome.
Gerli R; Bertotto A; Cernetti C; Agea E; Crupi S; Arcangeli C; Spinozzi F; Galandrini R; Rambotti P
Clin Exp Rheumatol; 1989; 7 Suppl 3():S129-34. PubMed ID: 2575023
[TBL] [Abstract][Full Text] [Related]
20. Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway.
Romano MF; Turco MC; Stanziola A; Giarrusso PC; Petrella A; Tassone P; van Lier R; Venuta S; Formisano S
Cell Immunol; 1993 May; 148(2):455-63. PubMed ID: 8098674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
